. 2023 Mar 16;24(6):5706. doi: 10.3390/ijms24065706

Table 5.

Significant associations of the individual rs6573604, rs11621121, rs10483776, and rs4073416 polymorphisms (genetic and allelic model) as well as the rs11621121–rs10483776 haplotypes with the plasma N-glycan levels in the PTSD patients.

Glycan Peak	Model	rs6573604		rs11621121		rs10483776		rs4073416		Haplo-Type
Glycan Peak	Model	H/U *	p	H/U *	p	H/U *	p	H/U *	p	Haplo-Type
GP16 (FA2G2S1)	Genetic	0.18	0.991	11.51	0.039	15.50	0.017	6.85	0.322	H = 21.10; p = 0.029
GP16 (FA2G2S1)	Allelic	23364.5	0.908	35666.5	0.020	24838.5	0.169	37340.5	0.176	H = 21.10; p = 0.029
GP20 (A2G2S2)	Genetic	2.82	0.683	7.82	0.156	6.19	0.160	3.92	0.687	H = 20.13; p = 0.109
GP20 (A2G2S2)	Allelic	22042.5	0.794	36544.5	0.039	26016.5	0.255	38474.5	0.341	H = 20.13; p = 0.109
GP22 (FA2G2S2)	Genetic	0.05	1.000	19.34	0.002	12.92	0.026	11.30	0.156	H = 29.04; p = 0.002
GP22 (FA2G2S2)	Allelic	23552.5	0.936	33526.5	0.001	23454.5	0.039	36856.5	0.351	H = 29.04; p = 0.002
GP23 (FA2BG2S2)	Genetic	0.94	0.938	12.78	0.039	9.19	0.065	7.69	0.273	H = 21.73; p = 0.026
GP23 (FA2BG2S2)	Allelic	23606.5	0.865	35466.5	0.013	26536.5	0.351	37268.5	0.208	H = 21.73; p = 0.026
GP31 (FA3G3S3)	Genetic	2.34	0.674	6.57	0.160	13.75	0.020	7.99	0.351	H = 20.77; p = 0.020
GP31 (FA3G3S3)	Allelic	22074.5	0.754	37016.5	0.045	23276.5	0.020	37588.5	0.195	H = 20.77; p = 0.020

* Data analyzed using the Kruskal–Wallis ANOVA of ranks for the genetic model and represented with the H value, or the Mann–Whitney U test for the allelic model and represented with the U value. Significant p-values (corrected using the Benjamini–Hochberg procedure) are denoted in bold.